Skip to content

The efficacy and neuroimaging study of transcutaneous auricular vagus nerve stimulation for Subjective Cognitive Decline in the elderly

The efficacy and neuroimaging study of transcutaneous auricular vagus nerve stimulation for Subjective Cognitive Decline in the elderly

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000185
Enrollment
Unknown
Registered
2025-01-25
Start date
2025-02-10
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjective Cognitive Decline

Interventions

sham-taVNS Group:Transcutaneous auricular non-vagal nerve stimulation

Sponsors

Dongzhimen Hospital Beijing University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria for subjective cognitive decline. 2.Subjective Cognitive Decline Questionnaire (SCD-Q) score > 5. 3.Memory decline is perceived subjectively rather than other cognitive functions. 4.Onset time = 5 years. 5.Age 55 - 80 years old with no less than 6 years of formal education no gender restriction right - handed. 6.No intake of any drugs for improving cognitive function (such as donepezil memantine rivastigmine galantamine huperzine compound cistanche intellectual capsule etc.) in the past 1 month and no acupuncture or neuromodulation treatment received. 7.Able to accept auricular acupoint electrical stimulation treatment and MRI scanning. 8.Normal corrected vision and hearing capable of completing neuropsychological cognitive assessment. 9.Signed informed consent form.

Exclusion criteria

Exclusion criteria: 1.Patients with mild cognitive impairment prodromal dementia or dementia. 2.Individuals whose cognitive decline can be explained by psychiatric disorders or neurological diseases (excluding Alzheimer's disease) internal medicine diseases drug side effects etc. 3.Patients with severe neuropsychiatric disorders serious heart lung liver kidney or hematopoietic system diseases and malignant tumors. 4.Individuals with contraindications for MRI examination such as metal teeth pacemakers stents or claustrophobia etc.

Design outcomes

Primary

MeasureTime frame
Auditory Verbal Learning Test of Huashan version;

Secondary

MeasureTime frame
Shape Trails Test A and B;Pittsburgh Sleep Quality Index;Subjective cognitive Decline questionnaire scale-9;fMRI;Montreal Cognitive Assessment Basic;Geriatric depression scale;Verbal fluency test;Stroop;sMRI;

Countries

China

Contacts

Public ContactShuai Zhang

Dongzhimen Hospital Beijing University of Chinese Medicine

drzhangs187@126.com18712233931

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026